Michael C Topf, MD
Otolaryngology · Nashville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Vanderbilt University Medical Center · 3,510 clinicians in this group
Hospitals listed: Vanderbilt University Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Topf’s office at (615) 322-3000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A160888 · Cancelled
Licence status: Cancelled · since 2019 · University of Rochester School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Tennessee 61177Medical Doctor · since 2020 · expires 2028-06-30Specialty on the licence: OtolaryngologyLicensedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
2 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- University of Rochester School of Medicine and Dentistry · MDRochester, NY · 2014Medical school
- Villanova University · PREMEDVillanova, PA · 2010
Residency and fellowship
- Fellowship, Head and Neck OncologyPalo Alto, CA · 2019–2020
- Residency, Otolaryngology - Head and Neck SurgeryPhiladelphia, PA · 2014–2019
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Vanderbilt University Medical CenterNashville, TNAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Vanderbilt Health, which runs 4 hospitalsHome of Vanderbilt-Ingram Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Postoperative hemorrhage or hematoma rate: 3.28 (2.41 to 4.15) · 6,585 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.2 (0.85 to 1.54) · 15,700 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.591, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.703, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,175 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Vanderbilt University Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.28 (2.41 to 4.15) · 6,585 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.2 (0.85 to 1.54) · 15,700 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.591 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.703 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,175 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.56 to 1.87) · 4,737 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.13 (0.97 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.72 (117.43 to 174.02) · 459 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.6 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 223 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.2 · 632 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.7 · 466 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 557 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 7,242 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.3 (0.14 to 0.46) · 17,585 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.05 to 0.37) · 18,947 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.16 (1.96 to 4.35) · 7,265 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.44 to 2.22) · 4,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.05 (6.38 to 11.73) · 4,115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.74 (3.02 to 6.45) · 4,325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.48 to 2.84) · 1,745 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 156 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 1.072 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.406 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.337 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 400 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 1,055 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -18 · 288 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.6 · 752 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -10.7 · 504 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 668 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.2 to 6.4) · 1,413 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (9.9 to 13) · 1,413 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 162 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.9 (8.8 to 13.5) · 4,301 cases | No different | Jan 2022 – Dec 2024 |
What patients said (1,643 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$74,107
Medicare paid this office $74,107 for 164 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of lymph nodes, muscle, and tissue of neck | 13 | $14,988 | $1,153 |
| Return visit (30+ min) | 63 | $6,194 | $70 |
| New patient visit (45+ min) | 47 | $4,615 | $98 |
| Diagnostic exam of voice box using a flexible endoscope | 55 | $3,822 | $48 |
| Long return visit (40+ min) | 24 | $3,025 | $112 |
See all 6 services
| Removal of lymph nodes, muscle, and tissue of neck | 13 | $14,988 | $1,153 |
| Return visit (30+ min) | 63 | $6,194 | $70 |
| New patient visit (45+ min) | 47 | $4,615 | $98 |
| Diagnostic exam of voice box using a flexible endoscope | 55 | $3,822 | $48 |
| Long return visit (40+ min) | 24 | $3,025 | $112 |
| Short return visit (20+ min) | 52 | $2,771 | $41 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 17 | More than 72% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Skin biopsy | 1-10 | None |
| Spinal fusion | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
164 Original Medicare patients in 2024. Average age 73 · Under 65 9% · 85 and older 9% · Women 34% · Also on Medicaid 7% · Health risk score 1.81. Sicker patients than 9 in 10 peers; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 74% · Coronary heart disease 30% · Diabetes 27% · Chronic kidney disease 27% · Depression 23% · Atrial fibrillation 21% · Cancer 16% · COPD 15% · Heart failure 13%.
The office billed $549,515, Medicare allowed $93,745 and paid $74,107; for 475 services of 78 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 164 | 475 | 73 | 1.81 | $549,515 | $74,107 |
| 2023 | 164 | 502 | 73 | 1.73 | $688,990 | $101,695 |
| 2022 | 145 | 478 | 72 | 1.78 | $568,665 | $90,261 |
| 2021 | 112 | 370 | 71 | 1.73 | $566,929 | $87,126 |
| 2020 | 64 | 129 | 71 | 2.39 | $184,775 | $30,769 |
| 2019 | 34 | 58 | 70 | 2.49 | $52,789 | $6,191 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Removal of lymph nodes, muscle, and tissue of neck | 18 | $19,848 | $1,045 |
| Return visit (30+ min) | 70 | $5,977 | $66 |
| New patient visit (45+ min) | 51 | $4,992 | $98 |
| Diagnostic exam of voice box using a flexible endoscope | 48 | $3,020 | $46 |
| Long return visit (40+ min) | 26 | $2,726 | $94 |
| Short return visit (20+ min) | 37 | $2,071 | $46 |
| Partial removal of external ear with simple repair | 11 | $1,775 | $148 |
2022: 6 services
| Removal of lymph nodes, muscle, and tissue of neck | 14 | $13,254 | $947 |
| Long return visit (40+ min) | 59 | $8,865 | $96 |
| Return visit (30+ min) | 52 | $4,970 | $67 |
| New patient visit (45+ min) | 40 | $3,977 | $99 |
| Diagnostic exam of voice box using a flexible endoscope | 44 | $3,292 | $48 |
| New patient visit (60+ min) | 12 | $1,610 | $134 |
2021: 7 services
| Removal of lymph nodes, muscle, and tissue of neck | 12 | $9,538 | $795 |
| Long return visit (40+ min) | 41 | $6,553 | $109 |
| New patient visit (60+ min) | 25 | $3,403 | $136 |
| New patient visit (45+ min) | 28 | $2,809 | $100 |
| Return visit (30+ min) | 25 | $2,195 | $71 |
| Diagnostic exam of voice box using a flexible endoscope | 31 | $2,134 | $50 |
| Incision of windpipe for insertion of breathing tube (older than 2 years) | 11 | $1,502 | $137 |
2020: 4 services
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 21 | $2,123 | $92 |
| New patient visit (45+ min) | 12 | $1,195 | $100 |
| Return visit (30+ min) | 11 | $611 | $56 |
| Short return visit (20+ min) | 11 | $479 | $40 |
2019: 1 service
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,611 | $90 |
Money from drug and device companies
$23,500 in 2025
| 2025 | 2 | 19 | $21,100 | $23,500 |
| 2024 | 1 | 1 | $1,908 | $1,908 |
| 2023 | 7 | 15 | None | $1,408 |
| 2022 | 3 | 6 | None | $378 |
| 2021 | 2 | 15 | None | $7,985 |
| 2020 | 1 | 1 | None | $75 |
| 2019 | 3 | 3 | None | $428 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Research & Development | None | $12,571 | 6 payments
|
| Regeneron Healthcare Solutions | Libtayo | $10,928 | 13 payments
|
See all 19 published payments
| Janssen Research & Development | Consulting · 2025-12-26 | None | $2,400 |
| Janssen Research & Development | Consulting · 2025-10-21 | None | $9,600 |
| Janssen Research & Development | Travel · 2025-10-21 | None | $410 |
| Regeneron Healthcare Solutions | Travel · 2025-10-15 | Libtayo | $762 |
| Regeneron Healthcare Solutions | Meals · 2025-10-15 | Libtayo | $57 |
| Regeneron Healthcare Solutions | Meals · 2025-10-15 | Libtayo | $145 |
| Regeneron Healthcare Solutions | Meals · 2025-10-15 | Libtayo | $36 |
| Janssen Research & Development | Meals · 2025-09-29 | None | $12 |
| Janssen Research & Development | Travel · 2025-09-25 | None | $0 |
| Janssen Research & Development | Travel · 2025-09-24 | None | $149 |
| Regeneron Healthcare Solutions | Consulting · 2025-09-19 | Libtayo | $5,460 |
| Regeneron Healthcare Solutions | Consulting · 2025-09-19 | Libtayo | $3,640 |
| Regeneron Healthcare Solutions | Travel · 2025-09-19 | Libtayo | $27 |
| Regeneron Healthcare Solutions | Travel · 2025-09-19 | Libtayo | $38 |
| Regeneron Healthcare Solutions | Travel · 2025-08-04 | Libtayo | $152 |
| Regeneron Healthcare Solutions | Travel · 2025-08-01 | Libtayo | $199 |
| Regeneron Healthcare Solutions | Travel · 2025-07-09 | Libtayo | $35 |
| Regeneron Healthcare Solutions | Travel · 2025-07-09 | Libtayo | $274 |
| Regeneron Healthcare Solutions | Meals · 2025-02-27 | Libtayo | $102 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,908
| Merck Sharp & Dohme | None | $1,908 | 1 payment
|
2023: $1,408
| KLS-Martin L.P. | None | $1,097 | 8 payments
|
| Acera Surgical | Restrata Wound Matrix | $145 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $58 | 2 payments
|
| Cook Medical | Cook-Swartz | $44 | 1 payment
|
| Stryker | Vsp System, Vsp Cranial | $27 | 1 payment
|
| Checkpoint Surgical | Checkpoint Stimulators | $22 | 1 payment
|
| KARL STORZ Endoscopy-America | Image 1 S | $16 | 1 payment
|
2022: $378
| KLS-Martin L.P. | None | $332 | 4 payments
|
| Stryker | Vsp System, Vsp Cranial | $34 | 1 payment
|
| DePuy Synthes Sales | Trumatch | $12 | 1 payment
|
2021: $7,985
| Intuitive Surgical | Da Vinci Surgical System | $6,994 | 7 payments
|
| KLS-Martin L.P. | None | $991 | 8 payments
|
2020: $75
| DePuy Synthes Sales | Trumatch | $75 | 1 payment
|
2019: $428
| Intuitive Surgical | Da Vinci Surgical System | $300 | 1 payment
|
| Tactile Systems Technology | Flexitouch | $86 | 1 payment
|
| DePuy Synthes Sales | Matrixmidface | $42 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 97.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1851711782
- Licence
- CA A160888, TN 61177California A160888: CancelledTennessee 61177: Licensed
- Trained
- University of Rochester School of Medicine and Dentistry, 2014
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 3841 Green Hills Village Dr Ste 200, Nashville, TN, 37215
- NPI first listed
- 2014-04-17
- NPI last updated
- 2022-03-14
- NPI record certified
- 2022-03-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305
This office lists an electronic records connection.